Bone Bone-anchored hearing aids are surgically implantable devices designed to treat hearing loss. This device works by transmitting the sound received through bone conduction to the nerve fibers in the inner ears. The bone-anchored hearing device is a niche segment in the bone-anchored hearing aids market. The bone-anchored hearing device consists of an externally worn receiver and a sound processor.
The sound processor resembles a standard behind-the-ear hearing aid, and there is an external abutment that helps the titanium implant to vibrate. It takes approximately 3 to 4 months for the implant to get fused with the living bone, and the process is termed as osseointegration. Once the bone-anchored hearing aid is osseointegrated, the implant conducts sound to the inner ear via the bone. Hence, the sound travels the inner bone without involving the ear canal or the middle ear. The hearing aids were approved by the FDA in 2002 for treating unilateral sensorineural hearing loss.
The growth of the bone-anchored hearing aids market is attributed to the increasing prevalence of hearing loss in children and older population. According to the WHO, annually 360 million individuals are affected with hearing loss, accounting for 5.3% of the total world population. An article published in CDC, stated that during the span of 1997 to 2007, 2 to 3 of 1,000 children, who were born in the U.S., faced hearing loss in one or both ears. Increasing customization in the product has proven beneficial for the users. The customization of hearing devices are done according to the users. For instance, in case of older people, the bone-anchored devices are designed in a way that they help in increasing the quality of digital sound. In addition, increasing demand for aesthetic hearing aids has propelled the growth of the bone-anchored hearing aids market.
Request a Brochure of Bone Anchored Hearing Aids Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26888
The global bone-anchored hearing aids market is segmented according to raw material, end-user, and geography. In terms of material, the global market is segmented into titanium alloy, ceramics composites, and others. In terms of end-user, the market is segmented into hospitals and medical centers. According to geography, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Globally, North America dominates the bone-anchored hearing aids market. Since technology is widely used in countries such as the U.S. and Canada, the demand for bone-anchored hearing aids is higher in North America. Increased use of medical technology and improved and developed health care are attributed for the market growth in Europe. Increasing health care services and rising patient pool are major drivers for the market growth in Asia Pacific. Hence, Asia Pacific is an emerging market for bone-anchored hearing aids during the forecast period. Rising health care infrastructure and facilities in Latin America are factors which are expected to drive the market growth in the region. Middle East & Africa is a slow growing market due to slow growth of economy in the countries of the region.
Request TOC of Bone Anchored Hearing Aids Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=26888
Major players operating in the bone-anchored hearing aids market are AUDITDATA, Cochlear Limited, GN ReSound, MED-EL Medical Electronics, Natus Medical Incorporated, Sivantos Group, Sonova Holding AG, Advanced Bionics Corporation, Phonak AG, Starkey Hearing Technologies, Widex, William Demant Holding, Bernafon AG, and Sonic Innovations.